Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, made the following post on X:
“Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma! Alveolar Soft Part Sarcoma is a rare cancer! Thanks for this NIH Director’s award! My last for work I did NCI CTEP Clinical Research! Thanks to National Institutes of Health, Genentech & FDA Oncology.”
Source: Elad Sharon/X